FREE LIGHT CHAINS (SERUM) | LABCORP OKLAHOMA INC.
The renal range of the κ/λ sFLC ratio: best strategy to evaluate multiple myeloma in patients with chronic kidney disease | BMC Nephrology | Full Text
Table 5 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
JCM | Free Full-Text | The Role of Light Kappa and Lambda Chains in Heart Function Assessment in Patients with AL Amyloidosis
5/7/2018 1 MULTIPLE MYELOMA: WHAT'S NEW?
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Myeloma Explained | Haematology | Oncology | onthewards
Cureus | Multiple Myeloma and Renal Failure: Mechanisms, Diagnosis, and Management | Article
Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease | PLOS ONE
Monoclonal gammopathy of renal significance: Early diagnosis is key | Nefrología
Table 4 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Final Diagnosis -- Case 701
Multiple myeloma: Diagnosis and management issues in patients with pre-existing chronic kidney disease
Serum free light chain assessment in monoclonal gammopathy and kidney disease | Nature Reviews Nephrology
Modeling the Effects of Multiple Myeloma on Kidney Function | Scientific Reports
Excluding myeloma diagnosis using revised thresholds for serum free light chain ratios and M-protein levels | Haematologica
Table 3 from Prevalence and clinical significance of abnormal serum kappa/lambda light chain ratio in patients with chronic kidney disease. | Semantic Scholar
Manni Mohyuddin on Twitter: "But when there is kidney dysfunction, the reticuloendothelial system becomes an important route for clearance!" / Twitter
The use of immunoglobulin light chain assays in the diagnosis of paraprotein-related kidney disease - ScienceDirect
PDF) The renal range of the κ/λ sFLC ratio: Best strategy to evaluate multiple myeloma in patients with chronic kidney disease
Distribution of serum FLC and kappa/lambda ratio in patients with renal... | Download Table
A PCP's Guide to Screening for Monoclonal Gammopathy of Undetermined Significance – Consult QD
Defining new reference intervals for serum free light chains in individuals with chronic kidney disease: Results of the iStopMM study | Blood Cancer Journal
